click below
click below
Normal Size Small Size show me how
DPT_NEURO_2
VASCULAR TERRITORIES
| Question | Answer |
|---|---|
| Anterior cerebral artery affects | Legs |
| Middle cerebral artery affects | Face. Arm, feet |
| Posterior cerebral artery affects | Vision |
| Artery commonly involved in stroke | Middle |
| Lobe of brain associated in expressive/brocha's aphasia | Frontal |
| Lobe of brain associated in receptive/wernicke's aphasia | Temporal |
| Lobe of brain associated in hemiparesis | Parietal |
| Lobe of brain associated in visual defects | Occipital |
| Difference between apraxia & agnosia | Inability to carry out & unable to recognize, respectively |
| It is the visual loss in same side | Homonymous hemnianopsia |
| One sided paralysis | hemiplegia |
| One sided weakness | Hemiparesis |
| hemiplegia & Hemiparesis is common in | Stroke |
| Assessment findings in right sided brain damage | LITIS Left hemiplagia Impaired judgement Time orientation Impulsive Short attention span |
| Assessment finding commonly seen with unilateral neglect | Right sided brain damage -> left hemiplegia |
| Assessment findings in left sided brain damage | MICAR Math & language problem Impared R&L discrimination Cautious (slow) Aphasia Right hemiplegia |
| Gold standard dx test for stroke | Brain plain CT scan |
| Findings of Brain plain CT scan in ischemic | Dark / hypodense |
| Findings of Brain plain CT scan in hemorrhagic | Bright / hyperdense |
| Type of stroke where it may hyave NORMAL Brain plain CT scan within 2 hrs | Ischemic |
| Dx test to determine site & extent of occlusion | Cerebral arteriography |
| Intervention during acute stage of stroke | Bed rest & NPO |
| Why obtain CBG in stroke | Bcz it may mask hypoglycemia |
| 2 drug given to ischemic stroke | Thrombolytic/fibrinolytic Antiplatelet |
| Thrombolytic/fibrinolytic MOA | Dissolve the clot |
| Nsg intervention prior to administration of Thrombolytic/fibrinolytic | Know onset of stroke |
| Golden period where Thrombolytic/fibrinolytic must be given in this time frame | 3-4.5 hrs |
| A/E of Thrombolytic/fibrinolytic | bleeding |
| What to avoid while on rTPA | HTN |
| C/I of rTPA | Active bleeding and BP of 185/110 |
| If anticoagulant is ordered during rTPA therapy, when to give | Atleast 24-48 hrs from rTPA to prevent bleeding |
| What to WOF in rTPA | Intracranial bleeding |
| Intervention if pt. taking rTPA is with signs of inc. ICP | Repeat CT scan |
| Intervention if pt. Taking rTPA is now with intracranial hemorrhage | Give Tranexamic acid |
| Drug for ischemic stroke to prevent plt. Aggregation | Anti8-plt therapy |
| Anti-plt therapy prevents | Formation of new clots |
| Surgical mgt in ischemic stroke | Mechanical thrombectomy |
| Mgt in ischemic stroke where it is the removal of clot through catheter | Mechanical thrombectomy |
| Entry point in Mechanical thrombectomy | Femoral/radial artery |
| Mechanical thrombectomy is done within | 6-24 hrs |
| Type of stroke where there is permissive HTN as a mgt | Ischemic |
| permissive HTN is to maintain | MAP of 110-130 |
| Position of ischemic | Flat on bed |
| Mgt. Of HTN in hemorrhagic | IV nicardipine & labetalol |
| Intervention for increased ICP in hemorrhagic | HOB : 15-30 Hyperventilate |